Invention Application
- Patent Title: MRI CONTRASTING AGENT FOR CONTRASTING CANCER CELL
- Patent Title (中): MRI对比剂代替癌症细胞
-
Application No.: US14670805Application Date: 2015-03-27
-
Publication No.: US20160089455A1Publication Date: 2016-03-31
- Inventor: Taeghwan Hyeon , Kun NA , Daishun LING , Wooram PARK
- Applicant: SNU R&DB FOUNDATION , Institute for Basic Science , The Catholic University of Korea Industry-Academic Cooperation Foundation
- Priority: KR10-2014-0129020 20140926
- Main IPC: A61K49/12
- IPC: A61K49/12 ; A61K49/18 ; C08G69/40 ; C08G81/00

Abstract:
The present invention relates to MRI contrasting agent for contrasting cancer cell which contains ultrafine nanoparticles. More particularly, the present invention is directed to a self-assembled ligand composition comprising a ligand A, which is separated at a specific pH range, and a ligand B of which surface charge changes at a specific pH range, MRI contrast agent for contrasting cancer cell comprising said ligand composition and MRI contrasting nanoparticles, and the methods for preparing them.
Public/Granted literature
- US09765187B2 MRI contrasting agent for contrasting cancer cell Public/Granted day:2017-09-19
Information query